HRT Financial’s Revelation Biosciences REVB Stock Holding History

HRT Financial’s Portfolio REVB Stock Details REVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17K	Buy	+16,978	New	+$18.4K	﹤0.01%	3946
2026 Q1	–	Sell	-3,830	Closed	-$12K	–	4573
2025 Q4	$12K	Buy	+3,830	New	+$16.8K	﹤0.01%	3034
2024 Q3	–	Sell	-88	Closed	-$32K	–	3015
2024 Q2	$32K	Buy	+88	New	+$36.3K	﹤0.01%	1887
2023 Q3	–	Sell	-3	Closed	-$17K	–	2975
2023 Q2	$17K	Buy	+3	New	+$18.8K	﹤0.01%	2112
2022 Q3	–	Hold	0	–	-$12K	–	3380
2022 Q2	–	Hold	0	–	–	–	2657
2022 Q1	–	Hold	0	–	–	–	2799
2021 Q4	–	Hold	0	–	–	–	2720

Other funds holding REVB

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

HRT Financial's REVB Position: Q2 2026 in Review

HRT Financial opened a new position in Revelation Biosciences (REVB) in Q2 2026: 16,978 shares worth $17K. The stake represents ﹤0.01% of the portfolio and ranks #3946 among its holdings. This is a return to the name: HRT Financial previously reported a position in REVB as recently as Q4 2025.

HRT Financial first reported a position in REVB in Q2 2023 and has held it in 4 quarters since. The position peaked at $32K in Q2 2024. 12 funds tracked by Wall St. Rank hold REVB as of Q2 2026.

HRT Financial held 16,978 shares of Revelation Biosciences worth $17K as of Q2 2026.
Revelation Biosciences was a new HRT Financial position in Q2 2026.
Revelation Biosciences made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3946 holding.
HRT Financial first reported a position in Revelation Biosciences in Q2 2023 and has held it in 4 quarters since.
HRT Financial's Revelation Biosciences position peaked at $32K in Q2 2024.
12 funds tracked by Wall St. Rank held Revelation Biosciences as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.